PHARMACY

Gilead voluntarily recalls one lot of injected AIDS-related infection drug

BY Alaric DeArment

FOSTER CITY, Calif. — Drug maker Gilead Sciences has recalled a single lot of an injected drug used to treat an opportunistic infection in AIDS patients due to the presence of foreign matter in some vials, the company said.

Gilead announced the voluntary recall of lot B120217A of Vistide (cidofovir), an injected drug used to treat cytomegalovirus retinitis in patients with AIDS, due to particulate matter.

The company said that it had not received any complaints related to the problem, but that patients risked experiencing serious complications if injected with the particles. The lot was distributed in the United States, Canada and Europe to retail pharmacies, hospitals and wholesalers.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Weis Markets names new VP pharmacy

BY Michael Johnsen

SUNBURY, Pa. —  Weis Markets on Monday promoted Rick Seipp to VP pharmacy. 

In his new position, Seipp will oversee the day-to-day merchandising, operation and management of Weis Markets’ 131 pharmacies. He will also oversee the company’s Lifestyle Initiatives’ team, which focuses on health and wellness issues.  

Seipp will report to Kurt Schertle, EVP sales and merchandising. Prior to his promotion, Seipp was the grocer’s director of pharmacy operations.

Prior to joining Weis in 2010, Seipp worked at Rite Aid. Earlier in his career, he worked as a store level pharmacist, pharmacy manager, pharmacy system development manager and district manager. 

Seipp is a graduate of Wilkes University’s School of Pharmacy and lives in Mechanicsburg, Pa.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Elimination of Saturday mail delivery could complicate mail-order business

BY Alaric DeArment

Eighty-eight members of the House of Representatives fired off a letter Monday to postmaster general and CEO of the U.S. Postal Service Patrick Donahoe urging the agency not to eliminate Saturday delivery of mail, saying it would impede the ability of people who depend on mail-order pharmacies to receive their medications.

It’s no secret that the retail pharmacy industry and pharmacy benefit managers don’t always see eye-to-eye, with the latter being the main provider of mail-order pharmacy services in the country and often touting them as an alternative to going to the drug store, while the former emphasize the face-to-face interaction with pharmacists not usually possible with mail-order. But between the back-and-forth, millions of patients still depend on mail order pharmacy, and the cost effectiveness that mail-order pharmacies frequently promote themselves as offering could be at risk if they must use more expensive delivery methods.

Many patients don’t have the option of going to pharmacies because of old age, disability or because they live in isolated, rural areas without convenient access to a pharmacy. In 2009, CVS Caremark delivered 50 million prescriptions through the mail, according to an op-ed by SVP mail pharmacy operations Kenneth Czarnecki that appeared in the Chicago Tribune in 2010. For many of those patients, particularly those living with chronic conditions and disease states that require precisely timed dosing, running out of medication and missing doses could have serious, long-term consequences.

As an alternative to shutting down Saturday delivery entirely, the representatives suggested exempting medications and allowing them to continue to be delivered then. Barring that, however, mail-order pharmacies would be forced to either make do with a five-day schedule or, the representatives wrote, use other, possibly more expensive delivery methods.

That could be a problem for a channel that has long promoted itself as a cheaper alternative to brick-and-mortar pharmacy retailers. In late 2012, specialty pharmacy patients – most of whom had conditions like HIV, cancer and autoimmune disorders – covered by Anthem Blue Cross started receiving letters from the insurer stating that their drugs would only be covered if they obtained them through CuraScript, Express Scripts’ mail-order specialty pharmacy business. A spokesman for Anthem told Drug Store News at the time that the move was intended to cut costs, though specialty pharmacies that had treated the patients balked, saying it would threaten continuity of care. In addition, according to experts, missing doses of some drugs, such as those that treat conditions like HIV, can cause the virus to become resistant to them.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?